TZU CHI BUDDHIST GENERAL HOSPITAL has a total of 12 patent applications. Its first patent ever was published in 2003. It filed its patents most often in Taiwan, Hong Kong and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are TROPHOGEN INC, FORSCHUNGSZENTRUM BORSTEL ZENT and CORTECS OM PTY LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Taiwan | 10 | |
#2 | Hong Kong | 1 | |
#3 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology | |
#4 | Measurement |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Climate change adaptation technologies | |
#5 | Microorganisms | |
#6 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Lin Shinn Zong | 3 |
#2 | Harn Horng Jyh | 3 |
#3 | Harn Horng-Jyh | 3 |
#4 | Chen Li Kuang | 3 |
#5 | Lin Shinn-Zong | 3 |
#6 | Lin Nien Tsung | 2 |
#7 | Tsai Nu-Man | 2 |
#8 | Liao Kuang-Wen | 1 |
#9 | Yang Kuo-Liang | 1 |
#10 | Lee Ming-Cheng | 1 |
Publication | Filing date | Title |
---|---|---|
TW201105797A | Phage of acinetobacter baumannii | |
TW201105241A | Bactericide composition comprising a phage | |
TW201030337A | Method and kit for detecting cancers | |
HK1100484A1 | Application of n-butylidenephthalide in preparing cancer treatment medication | |
TW200616656A | Pharmaceutical composition for inhibiting/treating brain cancer | |
TW200630613A | A method for screening compounds against flaviviruses infection by using persistent virus-infected cell systems | |
TW200609355A | Nurr1-positive neuron stem cells, pharmaceutical composition thereof and methods for their isolation, culture and preservation | |
TW200538141A | Method for extracting extract from chaenomeles lagenaria and the applications thereof |